Escalation Time to Open Triple Combination Therapy from the Initiation of LAMA versus ICS/LABA in COPD Management: Findings from Comparing the Incidence of Tiotropium and ICS/LABA in Real-World Use in South Korea (CITRUS) Study

Background: bronchodilators are the key treatment for chronic obstructive pulmonary disease (COPD), however, inhaled corticosteroids (ICSs)/long-acting β2-agonists (LABA) are widely prescribed. We compared the escalation time to open triple combination therapy between long-acting muscarinic receptor...

Descripción completa

Detalles Bibliográficos
Autores principales: Lee, Ye Jin, Rhee, Chin Kook, Hwang, Yong Il, Yoo, Kwang Ha, Lee, So Eun, Lee, Doik, Park, Yong Bum, Kim, Youlim
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8703927/
https://www.ncbi.nlm.nih.gov/pubmed/34945797
http://dx.doi.org/10.3390/jpm11121325

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8703927/
https://www.ncbi.nlm.nih.gov/pubmed/34945797
http://dx.doi.org/10.3390/jpm11121325

Ejemplares similares